Newspaper icon
The latest issue of Financial Standard now available as an e-newspaper
READ NOW

Search Results

Showing 6671 - 6680 of 22137 results for "Tim"

Pay cuts, dividend slashed as NAB raises capital

JAMIE WILLIAMSON  |  MONDAY, 27 APR 2020
The big bank has entered a trading halt as it looks to raise $3.5 billion to sustain the business throughout the COVID-19 downturn which has so far seen the interim dividend more than halved and the NAB leadership team take pay cuts. Releasing its 1H ...

Melbourne hedge fund quietly folds

KANIKA SOOD  |  FRIDAY, 24 APR 2020
A Melbourne fund manager started by former founders of RBS Morgan's ultra-high-net-worth division and backed by a family office is currently in the process of winding up. Qato Capital had three funds, in market neutral, long/short fund, and active share ...

LGIAsuper revises down unlisted assets

KANIKA SOOD  |  FRIDAY, 24 APR 2020
... superannuation funds are expected to come to surface later this month, as funds respond to the Standing Committee on Economics chair Tim Wilson's letter asking for details on unlisted assets among other questions. Managed funds land has also seen devaluations ...

Life insurers prepare for grilling

HARRISON WORLEY  |  FRIDAY, 24 APR 2020
... bodies will face up to the scrutiny of the House of Representatives Standing Committee on Economics, with committee chair Tim Wilson committing to grilling insurers on revelations from the Royal Commission, as well as issues raised by the COVID-19 pandemic. ...

IOOF, CountPlus, Iress want better path to fee consent

ELIZABETH MCARTHUR  |  FRIDAY, 24 APR 2020
Licensees and platform providers have joined forces to call for a consistent industry approach to managing the Advice Fee Consent legislation. The proposed legislation, which is part of the government's Royal Commission reforms, requires platform operators ...

Markets react as antiviral drug disappoints

ALLY SELBY  |  FRIDAY, 24 APR 2020
News that a highly anticipated antiviral drug hoped to treat COVID-19 had flopped in human trials saw markets fall overnight. Originally reported by the Financial Times, the publisher said Gilead Sciences antiviral drug remdesivir did not reduce the ...

Chief economist update: Turns out Brexit was heaven

BENJAMIN ONG  |  FRIDAY, 24 APR 2020
Bad timing it may be but, it is what it is. The coronavirus pandemic struck just when the dark clouds of Brexit uncertainty lifted over the United Kingdom. For the best part of three years, Brexit was on every Brits mind - dampening business investment ...

Compliance worse than COVID-19

ALLY SELBY  |  THURSDAY, 23 APR 2020
Regulatory and compliance burden is a bigger challenge and disruption for financial advisers than COVID-19, the global pandemic that has ripped both economies and lives to shreds. In an interview with Financial Standard, Investment Trends research director ...

The next big short

ALLY SELBY  |  THURSDAY, 23 APR 2020
Late last year, before extreme weather events battered the world, before COVID-19, The Big Short 's Michael Burry said he had found the next bubble: passive investments. Now, with asset prices trembling in the face of the pandemic, could there still ...

Aussie ETF investors got oil bets wrong before crash

KANIKA SOOD  |  THURSDAY, 23 APR 2020
Australians last week poured $35 million in the country's only ETF tracking crude oil futures, and were stung hard when WTI May contracts slipped into negative territory in Monday's trading. BetaShares Crude Oil Index ETF (OOO) tracks an index ...